Skip to main content

Advertisement

Table 1 Patient characteristics

From: Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes

  All patients (N = 98) Males (N = 73) Females (N = 25)
N 98 73 25
Age, years 66.2 ± 10.9 66.2 ± 11.0 66.9 ± 11.5
BMI, kg/m2 25.0 ± 4.0 25.5 ± 4.3 23.6 ± 3.0
WC, cm 89.3 ± 12.4 90.9 ± 13.0 84.1 ± 8.6
WHR 0.94 ± 0.08 0.96 ± 0.08 0.91 ± 0.07
Duration of diabetes, years 15.5 ± 11.8 15.9 ± 12.2 14.2 ± 10.2
HbA1c, % (mmol/mol) 8.9 ± 1.9 (73.5 ± 20.7) 9.0 ± 2.0 (74.5 ± 22.3) 8.6 ± 1.4 (70.4 ± 15.3)
FBS, mg/dL 156.9 ± 57.3 157.7 ± 62.1 154.9 ± 41.4
SBP, mmHg 132.1 ± 21.9 132.1 ± 20.6 132.2 ± 25.8
DBP, mmHg 72.1 ± 14.7 71.3 ± 14.2 74.3 ± 16.1
Total cholesterol, mg/dL 181.9 ± 39.4 179.2 ± 39.5 189.5 ± 39.2
HDL-cholesterol, mg/dL 43.8 ± 13.5 41.7 ± 13.2 49.7 ± 12.9
LDL-cholesterol, mg/dL 105.3 ± 31.7 104.4 ± 31.5 108.0 ± 32.9
Triglyceride, mg/dL 175.7 ± 107.5 181.7 ± 111.6 157.3 ± 94.0
IRI, IU/mL 8.9 ± 8.3 9.6 ± 9.2 6.8 ± 4.5
HOMA-IR 3.7 ± 4.3 4.1 ± 4.7 2.8 ± 2.5
BNP, pg/mL 57.7 ± 78.9 51.3 ± 64.7 82.6 ± 120.7
eGFR, mL/min/1.73 m2 61.1 ± 24.2 60.2 ± 25.2 63.6 ± 20.6
VFA-CT, cm2 116.1 ± 65.6 125.6 ± 70.9 88.4 ± 35.5
VFA-BIA, cm2 83.7 ± 46.0 91.0 ± 48.8 62.6 ± 27.9
Diabetes mellitus, N (%) 98 (100.0) 73 (100.0) 25 (100.0)
Hypertension, N (%) 72 (73.5) 55 (75.3) 17 (68.0)
Dyslipidemia, N (%) 88 (89.8%) 66 (90.4%) 22 (88.0%)
  1. Data are presented as mean ± standard deviation
  2. N number, BMI body mass index, WC waist circumference, WHR waist/hip ratio, HbA1c glycated hemoglobin, FBS fasting blood sugar, HDL high-density lipoprotein, LDL low-density lipoprotein, IRI immunoreactive insulin, HOMA-IR homeostasis model assessment for insulin resistance, eGFR estimated glomerular filtration rate, VFA visceral fat area, CT computed tomography, BIA bioelectric impedance analysis